Approved comparison material connected to this topic.
8 total recordsSource comparisons are presented without a generated winner.
CJC-1295 vs Ipamorelin: Differences, Dosing, and Stacking (2026) CJC-1295 vs Ipamorelin explained: different mechanisms, why they stack so well together, dosing protocols, side effects, and which to choose. Fr…
From Peptidepedia, the trusted peptide wiki. Medical Advisory Board
Both activate the GHS-R1a receptor, but their selectivity profiles diverge significantly. GHRP-6 produces robust GH release but also drives substantial increases in cortisol, prolactin, and appetite. The appet…
GHRP-2 sits between Ipamorelin and GHRP-6 in the selectivity spectrum. It produces a slightly stronger GH pulse than Ipamorelin but also elevates cortisol and prolactin to a modest degree. For users prioritizi…
Both are GHRH analogs targeting the same receptor, but they differ meaningfully in pharmacokinetics. Sermorelin is essentially the unmodified GHRH(1-29) fragment with a half-life of approximately 10 to 20 minu…
Tesamorelin is the only GHRH analog with current FDA approval (granted in 2010 for HIV-associated lipodystrophy). It uses an N-terminal trans-3-hexenoic acid modification for DPP-4 resistance, giving it a half…
Type: CJC-1295 is a GHRH analog; Ipamorelin is a growth hormone secretagogue (GHRP). Mechanism: CJC-1295 activates GHRH receptors on pituitary somatotrophs; Ipamorelin activates ghrelin receptors (GHS-R1a) on …
CJC-1295 exists in two functionally different forms, and the distinction matters significantly for protocol design. CJC-1295 with DAC includes a Drug Affinity Complex, a reactive lysine linker that covalently …